Testing effectiveness (Phase 2)Active Not RecruitingNCT03845712
What this trial is testing
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
Who this might be right for
Thymidine Kinase 2 Deficiency
UCB BIOSCIENCES, Inc. 47